• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    East Resources Acquisition Company filed SEC Form 8-K: Leadership Update

    2/15/24 4:54:23 PM ET
    $ERES
    Investment Managers
    Finance
    Get the next $ERES alert in real time by email
    abl-20240213
    false000181428700018142872024-02-132024-02-130001814287us-gaap:CommonStockMember2024-02-132024-02-130001814287us-gaap:WarrantMember2024-02-132024-02-13

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    __________________
    FORM 8-K
    __________________
    CURRENT REPORT
    Pursuant to Section 13 or Section 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): February 13, 2024
    __________________
    Abacus Life, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware
    (State or other jurisdiction of incorporation
    or organization)
    001-39403
    (Commission
    File Number)
    85-1210472
    (I.R.S. Employer
    Identification Number)
    2101 Park Center Drive, Suite 200
    Orlando, Florida 32835
    (800) 561-4148
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
    __________________
    (Former name or former address, if changed since last report)
    __________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
    o
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    o
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    o
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    o
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolsName of each exchange on which registered
    Common stock, par value $0.0001 per shareABLThe NASDAQ Stock Market LLC
    Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per shareABLLWThe NASDAQ Stock Market LLC
    Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028ABLLLThe NASDAQ Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
    Emerging growth company    x
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    x



    Item 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.


    2024 Corporate Objectives and Bonus Program Information
    On February 13, 2024, upon recommendation of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Abacus Life, Inc. (the “Company”), the Board approved the Company’s 2024 annual incentive plan for named executive officers of the Company. Upon the achievement of certain 2024 Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”) growth targets, a named executive officer can achieve an annual bonus of between 50% and 200% of 2024 beginning base salary. Based on individual performance, the amount of any annual bonus may be adjusted (up or down) by 10% of base salary. The annual bonus may consist of both cash and equity, with the percentage of cash ranging from 25% to 100% of the bonus amount. The form and terms of any equity awarded will be determined by the Company at the time of grant.

    2024 Long Term Incentive Awards
    In addition, the Committee granted equity awards (the “Equity Awards”) under the Company’s 2023 Long-Term Equity Compensation Incentive Plan (the “Plan”) and award agreements, consisting of (i) 24,000 restricted stock units (the “RSUs”) to each of Messrs. Jackson and McNealy and 12,000 RSUs to Mr. McCauley, and (ii) 76,725 options to purchase the Company’s common stock at the closing price on February 12, 2024 (the “Options”) to each of Messrs. Jackson, and McNealy and 38,363 Options to Mr. McCauley.

    The Options will have a term of 10 years. The Equity Awards will vest equally on each of the first three anniversaries of the grant date. Each grantee must remain employed through the end of the applicable vesting period to receive any award under the Plan, except that he may be entitled to a prorated portion of the award in the event of involuntary termination without cause, death, disability or retirement. In addition, in the event of such a termination in connection with a change in control, all unvested awards generally vest immediately. A change in control is defined in the Plan generally as an event that would be considered as a change in control in the Treasury Regulations published under Section 409A of the Code.




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
    Abacus Life, Inc.
    Date: February 15, 2024By:/s/ Jay Jackson
    Name:Jay Jackson
    Title:Chief Executive Officer

    Get the next $ERES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ERES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ERES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jackson Jay J

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 9:03:41 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form 4 filed by Mccauley William Hugh Jr

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 9:00:58 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form 4 filed by Kirby Kevin Scott

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    2/15/24 8:58:21 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Gusky Adam Samuel bought $74,481 worth of shares (12,200 units at $6.10), increasing direct ownership by 116% to 22,718 units (SEC Form 4)

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    11/20/23 6:57:24 PM ET
    $ERES
    Investment Managers
    Finance

    Mcnealy Sean bought $1,851 worth of shares (300 units at $6.17), increasing direct ownership by 0.00% to 12,593,550 units (SEC Form 4)

    4 - Abacus Life, Inc. (0001814287) (Issuer)

    11/20/23 6:15:43 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    SEC Filings

    View All

    East Resources Acquisition Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:56:14 PM ET
    $ERES
    Investment Managers
    Finance

    East Resources Acquisition Company filed SEC Form 8-K: Leadership Update

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:54:23 PM ET
    $ERES
    Investment Managers
    Finance

    East Resources Acquisition Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Abacus Life, Inc. (0001814287) (Filer)

    2/15/24 4:51:51 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    East Resources Acquisition Company and Abacus Life Announce Completion of Business Combination

    ERES Shareholders Approved the Business Combination on June 29, 2023 Abacus Life to begin trading on Nasdaq on July 5, 2023 under ticker symbol "ABL" East Resources Acquisition Company (NASDAQ:ERES) ("ERES"), a publicly traded special purpose acquisition company, today announced the completion of its business combination with Abacus Life, a leading buyer of life insurance policies and a vertically integrated alternative asset manager specializing in specialty insurance products. ERES shareholders voted to approve the business combination at a meeting held on June 29, 2023. In connection with the completion of the business combination, ERES has been renamed "Abacus Life, Inc." ("Abacus

    7/3/23 8:00:00 AM ET
    $ERES
    Investment Managers
    Finance

    Abacus Life to Participate in Fireside Chat with IPO Edge and The Palm Beach Hedge Fund Association Friday, June 23 at 9:00am ET

    Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, will participate in a virtual fireside chat with The Palm Beach Hedge Fund Association and IPO Edge Friday, June 23, 2023 at 9:00am ET. The live event will feature Abacus President and CEO, Jay Jackson and will be moderated by IPO Edge Editor-in-Chief John Jannarone who will discuss: Abacus' business combination with East Resources Acquisition Company (NASDAQ:ERES); Current ownership structure and growth story; Abacus' business

    6/22/23 8:00:00 AM ET
    $ERES
    Investment Managers
    Finance

    Abacus Life Continues to Expand Market Share in Life Settlement Payouts

    Abacus Pays 11% More per Policy Than its Closest Competitor Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, announced today that according to financial publication The Deal, the Company continued to expand its market share in the life settlement industry and remained a leader in life settlement payouts in 2022, bringing premier value to its clients. The Deal report evaluates life settlement providers based on the number of policies purchased and value. For 2022, while the life settl

    6/15/23 2:11:00 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Leadership Updates

    Live Leadership Updates

    View All

    Abacus Life Appoints New Managing Director

    Abacus Settlements, LLC (d/b/a Abacus Life) and Longevity Market Assets, LLC (together "Abacus" or the "Company"), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today announced that Nicholas Sawuk has joined the Company as Managing Director. Sawuk brings nearly 20 years of experience in financial services and life settlements and has worked for companies such as a European Life Settlement Fund with its own life settlement provider, as well as Cantor Fitzgerald on Cantor Insurance Group's life settlement and insurance-linked securities desk in New York. Most recently, Sawuk served as the of Head

    6/8/23 4:15:00 PM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Financials

    Live finance-specific insights

    View All

    Abacus Life, a Leading Buyer of Life Insurance Policies and Vertically Integrated Alternative Asset Manager, to Become Public Company

    - Abacus Life and East Resources Acquisition Company (NASDAQ:ERES) enter business combination agreement - Sector leader within an uncorrelated alternative asset class with a $233 billion TAM, institutional investment grade counterparts and outsized growth potential, underpinned by steady financial performance - Proprietary technology platform yields differentiated underwriting capabilities - Transaction implies pro-forma enterprise value of $618 million; proceeds to be used to reduce cost of capital, scale hold portfolio and begin securitizing policy portfolios - Anticipated transaction close as early as the fourth quarter of 2022 - Combined company's shares of common stock expected to

    8/30/22 6:30:00 AM ET
    $ERES
    Investment Managers
    Finance

    $ERES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by East Resources Acquisition Company (Amendment)

    SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)

    2/13/24 2:13:50 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by East Resources Acquisition Company (Amendment)

    SC 13G/A - Abacus Life, Inc. (0001814287) (Subject)

    2/12/24 4:48:07 PM ET
    $ERES
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by East Resources Acquisition Company (Amendment)

    SC 13D/A - Abacus Life, Inc. (0001814287) (Subject)

    10/20/23 4:37:06 PM ET
    $ERES
    Investment Managers
    Finance